Reported 2 months ago
Despite Johnson & Johnson's strong market presence, its growth has stagnated, leading analysts to predict that Vertex Pharmaceuticals and Intuitive Surgical could surpass its market cap in the next ten years. Vertex, with its rapid growth driven by Cystic Fibrosis treatments and new therapies on the horizon, and Intuitive Surgical, leading the robotic surgery market despite some recent challenges, are both well-positioned for significant growth.
Source: YAHOO